Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Conditions: Sarcoma; Desmoplastic Small Round Cell Tumor (DSRCT)Intervention: Drug: irinotecan, temozolomide, and bevacizumab incorporated into an existing schedule of high dose alkylatorSponsors: Memorial Sloan Kettering Cancer Center; Genentech, Inc.Recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer & Oncology | Chemotherapy | Desmoplastic Small Round Cell Tumor (DSRCT) | Research | Sarcomas | Temodar